The tablet should be swallowed whole - do not split, crush or chew it
Ecnoglutide vs Semaglutide: Biased GLP-1 Agonist vs Proven Standard of Care Evidence-based comparison of ecnoglutide (cAMP-biased GLP-1 agonist) and semaglutide (selective GLP-1 agonist), including SLIMMER Phase 3, STEP, and SELECT trial data
It may contain little, or no active ingredient, or higher than the needed amount of active ingredient, which may affect the effectiveness of the medication
Reduces appetite and increases satiety to support sustainable weight management Enhances insulin sensitivity and reduces post-meal glucose spikes to help maintain healthy glucose levels Acts on brain pathways that control hunger and food intake Improved weight and metabolic control may help reduce risk factors associated with cardiometabolic disease Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone involved in regulating appetite, insulin secretion, and blood sugar levels
Slowing down while eating and practicing mindful consumption allows you to recognize the fullness signals that Semaglutide is amplifying, preventing you from overeating before the brain catches up to the stomach
If appetite feels steady and relentless, semaglutide often targets that pattern
